• Je něco špatně v tomto záznamu ?

Comparing the incidence of ventricular arrhythmias during epicardial ablation in swine versus canine models

G. Caluori, A. Wojtaszczyk, O. Yasin, M. Pesl, J. Wolf, S. Belaskova, M. Crha, A. Sugrue, VR. Vaidya, N. Naksuk, CV. DeSimone, AM. Killu, D. Padmanabhan, SJ. Asirvatham, Z. Stárek,

. 2019 ; 42 (7) : 862-867. [pub] 20190429

Jazyk angličtina Země Spojené státy americké

Typ dokumentu srovnávací studie, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20025811

BACKGROUND: Choosing the appropriate animal model for development of novel technologies requires an understanding of anatomy and physiology of these different models. There are little data about the characteristics of different animal models for the study of technologies used for epicardial ablation. We aimed to compare the incidence of ventricular arrhythmias during epicardial radiofrequency ablation between swine and canine models using novel epicardial ablation catheters. METHODS: We conducted a retrospective study using data obtained from epicardial ablation experiments performed on swine (Sus Scrofa) and canine (Canis familiaris) models. We compared the incidence of ventricular arrhythmias during ablation between swine and canine using multivariate regression analysis. Six swine and six canine animals underwent successful epicardial radiofrequency ablation. A total of 103 ablation applications were recorded. RESULTS: Ventricular arrhythmias requiring cardioversion occurred in 13.11% of radiofrequency ablation applications in swine and 9.75% in canine (relative risk: 117.6%, 95% confidence interval [CI]: 83.97-164.69, animal-based odds ratio [OR]: .55, 95% CI: .23-61.33; P = .184). When adjusting for application position, duration of ablation and power, the odds of developing potentially lethal ventricular arrhythmia in swine increased significantly compared to canine (OR: 3.60, 95% CI: 1.35-9.55; P = .010). CONCLUSIONS: The swine myocardium is more susceptible to developing ventricular arrhythmias compared to canine model during epicardial ablation. This issue should be carefully considered in future studies.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20025811
003      
CZ-PrNML
005      
20201222155440.0
007      
ta
008      
201125s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1111/pace.13698 $2 doi
035    __
$a (PubMed)30989679
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Caluori, Guido $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic. CEITEC, Masaryk University, Brno, Czech Republic.
245    10
$a Comparing the incidence of ventricular arrhythmias during epicardial ablation in swine versus canine models / $c G. Caluori, A. Wojtaszczyk, O. Yasin, M. Pesl, J. Wolf, S. Belaskova, M. Crha, A. Sugrue, VR. Vaidya, N. Naksuk, CV. DeSimone, AM. Killu, D. Padmanabhan, SJ. Asirvatham, Z. Stárek,
520    9_
$a BACKGROUND: Choosing the appropriate animal model for development of novel technologies requires an understanding of anatomy and physiology of these different models. There are little data about the characteristics of different animal models for the study of technologies used for epicardial ablation. We aimed to compare the incidence of ventricular arrhythmias during epicardial radiofrequency ablation between swine and canine models using novel epicardial ablation catheters. METHODS: We conducted a retrospective study using data obtained from epicardial ablation experiments performed on swine (Sus Scrofa) and canine (Canis familiaris) models. We compared the incidence of ventricular arrhythmias during ablation between swine and canine using multivariate regression analysis. Six swine and six canine animals underwent successful epicardial radiofrequency ablation. A total of 103 ablation applications were recorded. RESULTS: Ventricular arrhythmias requiring cardioversion occurred in 13.11% of radiofrequency ablation applications in swine and 9.75% in canine (relative risk: 117.6%, 95% confidence interval [CI]: 83.97-164.69, animal-based odds ratio [OR]: .55, 95% CI: .23-61.33; P = .184). When adjusting for application position, duration of ablation and power, the odds of developing potentially lethal ventricular arrhythmia in swine increased significantly compared to canine (OR: 3.60, 95% CI: 1.35-9.55; P = .010). CONCLUSIONS: The swine myocardium is more susceptible to developing ventricular arrhythmias compared to canine model during epicardial ablation. This issue should be carefully considered in future studies.
650    _2
$a zvířata $7 D000818
650    _2
$a katetrizační ablace $x metody $7 D017115
650    12
$a modely nemocí na zvířatech $7 D004195
650    _2
$a psi $7 D004285
650    _2
$a incidence $7 D015994
650    _2
$a perikard $x chirurgie $7 D010496
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a prasata $7 D013552
650    _2
$a komorová tachykardie $x etiologie $7 D017180
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
700    1_
$a Wojtaszczyk, Adam $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic. 3rd Department of Cardiology, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, Katowice, Poland.
700    1_
$a Yasin, Omar $u Division of Cardiovascular Disease, Mayo Clinic, Rochester, Minnesota.
700    1_
$a Pesl, Martin $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic. First Department of Internal Medicine/Cardioangiology, St. Anne´s Hospital, Masaryk University, Brno, Czech Republic. Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
700    1_
$a Wolf, Jiří $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.
700    1_
$a Belaskova, Silvie $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.
700    1_
$a Crha, Michal $u University of Veterinary and Pharmaceutical Sciences, Brno, Czech Republic.
700    1_
$a Sugrue, Alan $u Division of Cardiovascular Disease, Mayo Clinic, Rochester, Minnesota.
700    1_
$a Vaidya, Vaibhav R $u Division of Cardiovascular Disease, Mayo Clinic, Rochester, Minnesota.
700    1_
$a Naksuk, Niyada $u Division of Cardiovascular Disease, Mayo Clinic, Rochester, Minnesota.
700    1_
$a DeSimone, Christopher V $u Division of Cardiovascular Disease, Mayo Clinic, Rochester, Minnesota.
700    1_
$a Killu, Ammar M $u Division of Cardiovascular Disease, Mayo Clinic, Rochester, Minnesota.
700    1_
$a Padmanabhan, Deepak $u Division of Cardiovascular Disease, Mayo Clinic, Rochester, Minnesota.
700    1_
$a Asirvatham, Samuel J $u Division of Cardiovascular Disease, Mayo Clinic, Rochester, Minnesota. Department of Pediatrics and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota.
700    1_
$a Stárek, Zdeněk $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic. First Department of Internal Medicine/Cardioangiology, St. Anne´s Hospital, Masaryk University, Brno, Czech Republic.
773    0_
$w MED00003671 $t Pacing and clinical electrophysiology : PACE $x 1540-8159 $g Roč. 42, č. 7 (2019), s. 862-867
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30989679 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201222155436 $b ABA008
999    __
$a ok $b bmc $g 1599956 $s 1116497
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 42 $c 7 $d 862-867 $e 20190429 $i 1540-8159 $m Pacing and clinical electrophysiology $n Pacing Clin Electrophysiol $x MED00003671
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Možnosti archivace